244 related articles for article (PubMed ID: 21967132)
1. Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2012 Mar; 166(3):642-5. PubMed ID: 21967132
[TBL] [Abstract][Full Text] [Related]
2. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.
Hoeger PH; Nanduri VR; Harper JI; Atherton DA; Pritchard J
Arch Dis Child; 2000 Jun; 82(6):483-7. PubMed ID: 10833183
[TBL] [Abstract][Full Text] [Related]
3. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
4. Topical nitrogen mustard: an effective treatment for cutaneous Langerhans cell histiocytosis.
Sheehan MP; Atherton DJ; Broadbent V; Pritchard J
J Pediatr; 1991 Aug; 119(2):317-21. PubMed ID: 1861222
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard.
Bui AN; Puleo AE; Canales AL; Jacobsen ED; LeBoeuf NR
J Drugs Dermatol; 2020 Aug; 19(8):803-805. PubMed ID: 32845598
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Langerhans cell histiocytosis - an indication for dermatological pharmacotherapy with topical nitrogen mustard.
Schlinsog AS; Kreft B; Marsch WC
J Dtsch Dermatol Ges; 2018 Sep; 16(9):1133-1135. PubMed ID: 30112832
[No Abstract] [Full Text] [Related]
7. Langerhans cell histiocytosis: an uncommon presentation, successfully treated by thalidomide.
Shahidi-Dadras M; Saeedi M; Shakoei S; Ayatollahi A
Indian J Dermatol Venereol Leprol; 2011; 77(5):587-90. PubMed ID: 21860158
[TBL] [Abstract][Full Text] [Related]
8. [Isolated cutaneous Langerhans histiocytosis. Clinical and immunohistologic improvement after local application of nitrogen mustard].
Thivolet J; Cambazard F; Euvrard S; Hermier M; Kanitakis J
Ann Dermatol Venereol; 1984; 111(8):765-6. PubMed ID: 6397098
[No Abstract] [Full Text] [Related]
9. [Topical therapy using nitrogen mustard (chlormethine hydrochlorate) for cutaneous manifestations of histiocytosis X (author's transl)].
Lemarchand-Venencie F; Saurat JH
Ann Pediatr (Paris); 1982 Jan; 29(1):70-3. PubMed ID: 6976769
[No Abstract] [Full Text] [Related]
10. Topical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalp.
Treat JR; Suchin KR; James WD
J Dermatolog Treat; 2003 Jan; 14(1):46-7. PubMed ID: 12745855
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
12. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Langerhans-cell histiocytosis by oral cyclosporin A and topical nitrogen mustard].
Forssman T; Fluhr J; Djawari D; Gloor M; Rumpelt HJ
Ann Dermatol Venereol; 1994; 121(10):734. PubMed ID: 7793767
[No Abstract] [Full Text] [Related]
14. A phase II trial using thalidomide for Langerhans cell histiocytosis.
McClain KL; Kozinetz CA
Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Langerhans cell histiocytosis in children under one year.
Lau L; Krafchik B; Trebo MM; Weitzman S
Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
18. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
Lindahl LM; Fenger-Gron M; Iversen L
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):163-8. PubMed ID: 22229501
[TBL] [Abstract][Full Text] [Related]
19. Histiocytosis X in two infants--treated with topical nitrogen mustard.
Zachariae H
Br J Dermatol; 1979 Apr; 100(4):433-8. PubMed ID: 313216
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide.
Sander CS; Kaatz M; Elsner P
Dermatology; 2004; 208(2):149-52. PubMed ID: 15057007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
